|
Psoriasis Headquarters
Welcome to Psoriasis Headquarters, the center for free CME and CE courses and the most up-to-date information on psoriatic arthritis and psoriasis treatments. Here you will find the latest research data, expert opinions, and medical training to earn CME and CE credits as you increase your knowledge of these conditions.
Ask The Expert
Ask the Expert, Jeffrey Weinberg, MD, challenging questions regarding psoriatic conditions!
Jeffrey M Weinberg, MD, FAAD
Assistant Clinical Professor
Columbia University College of Physicians and Surgeons
New York, NY
Latest Questions (Click question for answer)
- It seems common that psoriasis flares up when other health conditions do. should we look for a trigger, or just treat the flare?
Answer: Psoriasis has several well-known triggers, including some medications, infections, skin injury, and stress. The major reason to look for a trigger is that, if this factor can be removed, the psoriasis may abate. Several years ago, a young woman presented with nail complaints consistent with psoriasis. Upon taking her history, she was taking lithium for bipolar disorder. The changing of this medication improved her nail dystrophy. Therefore, a detailed history, including potential triggers, may be useful and should be performed. If there is no obvious trigger, appropriate therapy can be instituted.
- Any tricks for treating widespread guttate psoriasis in children/young adults?
Answer: Guttate psoriasis can often present a therapeutic challenge, given its diffuse and patchy nature. Obviously topical therapy and phototherapy are options, but there are limitations to both of these. It is hard to apply topicals to diffuse guttate lesions, and phototherapy, while effective, can often be inconvenient. In the setting of streptococcal pharyngitis, a positive throat culture, or a positive AASO titer, an empiric course of antibiotics may be an option to remove the potential stimulus for the guttate flare. In extreme cases, a short course of systemic therapy, with appropriate monitoring, may be an option.
- When do you typically decide to start a patient with psoriasis on a systemic agent?
Answer: Although practitioner experience as well as clinician and patient preferences guide the answer to this question, some general guidelines can be recommended: Patients with psoriasis and psoriatic arthritis should be started on an anti-TNF agent with or without methotrexate. Patients with limited psoriasis may respond to topical therapy or targeted phototherapy while individuals with extensive disease are candidates for systemic intervention, which may include UVB/PUVA, traditional systemic (eg, cyclosporine), or biologic agents. In addition, patients with limited disease who do not respond to topical or targeted phototherapy should be considered for treatment with a traditional systemic or biologic.
Today's Poll
Highlights
|
|
|
|
|
CME/CE
|
|
CME
0.50 AMA PRA Category 1 Credit(s)™
|
|
|
|
|
Editorial Advisory Board
Ellen H Frankel, MD
Chief Dermatology, St Joseph’s Hospital
President of the PHO, Kent County Memorial Hospital
Private Practice, Cranston, RI
Clinical Partners, LLC
Johnston, Rhode Island
Kristine J Kucera, PA-C, MPAS, DHS
Texas Dermatology Associates
Adjunct Clinical Instructor
University of Texas Southwestern Medical Center
Dallas, Texas
 David M Pariser, MD, FACP, FAAD
Professor, Department of Dermatology
Eastern Virginia Medical School
Norfolk, Virginia
Melodie Young, RN, MSN, ANP-C, GNP-C
Adjunct Clinical Instructor
The University of Texas at Arlington
Modern Dermatology
Baylor Health Care System
Dallas, Texas
Click here for Credentials, Biographies, and Disclosures
Faculty & FDA Disclosure Statement
In accordance with Policy, presenters have indicated if they have a conflict of interest, and if so, it has been resolved.
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. |
Complimentary
CME/CE Activities
In The Headlines Tan, J.Y. et al.
Meta-analysis of ustekinumab trials in psoriasis shows significant improvement over placebo. J Dermatol Treatment. 2011, 22:323.
View Abstract
Marrakchi S et al.
A Psoriasis Gene Emerges: IL-36-Receptor Antagonist Deficiency Causes Generalized Pustular Psoriasis. N Engl J Med. 2011. Aug 18; 365:620.
View Abstract
Huber, A.M. et al.
Treatment consensus published for moderate juvenile dermatomyositis. Arthr Care Res. 2011, 63(11), Advance publication).
View Abstract
Schaarschmidt, M-L. et al.
Treatment location most important in ranking of patient preferences for psoriasis treatments. Arch Dermatol. 2011, 147(11):1285.
View Abstract
Otten MH et al.
Factors associated with treatment response to etanercept in juvenile arthritis. JAMA 2011 Dec 7; 306:2340.
View Abstract
Ahlehoff O et al.
Psoriasis and risk of atrial fibrillation and ischaemis stroke: A Danish Nationwide Cohort Study. Eur Heart J 2011. Aug 12; [e-pub ahead of print].
View Abstract
Balato, N. et al.
Psoriasis may confer protection against melanocytic progression to nevi. Br J Dermatol 2011, 164: 1262.
View Abstract
Marrakchi S et al.
Interluekin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011, Aug 18; 365:620.
View Abstract
Upcoming Conferences
Orlando Dermatology Conference
January 13-16, 2012
Orlando, FL
Dermatology Nurses' Association
30th Annual Convention
February 16-19, 2012
Denver, CO
10th Annual South Beach Symposium
South Beach Clinical Dermatology Symposium
February 16-19, 2012
Miami, FL
70th Annual Meeting of the American Academy of Dermatology
March 16-20, 2012
San Diego, CA
2012 Atlantic Dermatological Conference
April 27-29, 2012
New York, NY
Alabama Dermatology Society
"SEMINAR IN THE CITY"
May 25-28, 2012
New York, NY
Society of Dermatology Physician Assistants
"DERMATOLOGY SUMMER SYMPOSIUM"
June 21 - June 24, 2012
Sandestin, FL
Society of Dermatology Physician Assistants
Summer Dermatology Conference 2012
July 11-15, 2012
The Westin Hotel
Seattle, WA
American Academy of Dermatology
Summer Meeting
August 15-19, 2012
Boston, MA
Feedback Form
What would you like to see on this page?
|
Practice with the Experts Volume 4 Issue 4
